MeghanCaitlinThompsonMD
Internal Medicine • Basking Ridge, NJHematology/Oncology
Assistant Attending, Leukemia Service, Memorial Sloan Kettering Cancer Center
Overview of Dr. Thompson
Dr. Meghan Thompson is an internist in Basking Ridge, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Ohio State University College of Medicine and has been in practice 0 years. She is one of 237 doctors at Memorial Sloan Kettering Cancer Center and one of 4 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Internal Medicine. She has more than 20 publications and over 450 citings.
Office
136 Mountain View Boulevard
Basking Ridge, NJ 07920
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
University of Pennsylvania Health SystemResidency, Internal Medicine, 2016 - 2019
Ohio State University College of MedicineClass of 2016
Princeton UniversityA.B., Economics, 2007 - 2011
Certifications & Licensure
NJ State Medical License 2022 - 2025
NY State Medical License 2020 - 2025
PA State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 48 citationsCOVID-19 in patients with CLL: improved survival outcomes and update on management strategies.Lindsey E. Roeker, Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff
Blood. 2021-07-23 - 97 citationsMechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.Eric Wang, Xiaoli Mi, Meghan C Thompson, Skye Montoya, Ryan Q Notti
The New England Journal of Medicine. 2022-02-24 - 119 citationsReal world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United StatesAnthony R. Mato, Meghan C. Thompson, John N. Allan, Danielle M. Brander, John M. Pagel
Haematologica. 2018-09-01
Press Mentions
How to Manage Venetoclax Resistance in Chronic Lymphocytic LeukemiaJune 23rd, 2021- Triple Therapy for CLL Shows Promise in Phase 2 TrialSeptember 21st, 2020
- MSK Research Highlights, February 12, 2024February 13th, 2024
Research History
- Research AssistantCenter for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital2011 - 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
